Article
Decreased Soluble Guanylate Cyclase Contributes to Cardiac Dysfunction Induced by Chronic Doxorubicin Treatment in Mice.
Antioxidants & redox signaling - 1 Feb 2017
Vandenwijngaert Sara, Swinnen Melissa, Walravens Ann-Sophie, Beerens Manu, Gillijns Hilde, Caluwé Ellen, Tainsh Robert E, Nathan Daniel I, Allen Kaitlin, Brouckaert Peter, Bartunek Jozef, Scherrer-Crosbie Marielle, Bloch Kenneth D, Bloch Donald B, Janssens Stefan P, Buys Emmanuel S
Abstract excerpt
AIMS: The use of doxorubicin, a potent chemotherapeutic agent, is limited by cardiotoxicity. We tested the hypothesis that decreased soluble guanylate cyclase (sGC) enzyme activity contributes to the development of doxorubicin-induced cardiotoxicity. RESULTS: Doxorubicin administration (20 mg/kg, intraperitoneally [IP]) reduced cardiac sGC activity in wild-type (WT) mice. To investigate whether decreased sGC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
